Transaction DateRecipientSharesTypePriceValue
20th January 2021David J Matlin2,426Grant/award etc.$0.00
29th December 2020Wtt Med Avail Ltd Abg45Open or private purchase$14.00$630.00
29th December 2020Wtt Med Avail Ltd Abg55Open or private purchase$14.00$770.00
28th December 2020Wtt Med Avail Ltd Abg3,894Open or private purchase$13.98$54,424.88
28th December 2020Wtt Med Avail Ltd Abg3,213Open or private purchase$13.98$44,906.82
17th December 2020Wtt Med Avail Ltd Abg6,946Open or private purchase$13.12$91,132.21
17th December 2020Wtt Med Avail Ltd Abg5,731Open or private purchase$13.12$75,191.29
17th December 2020Wtt Med Avail Ltd Abg1,248Open or private purchase$14.00$17,472.00
17th December 2020Wtt Med Avail Ltd Abg1,029Open or private purchase$14.00$14,406.00
16th December 2020Wtt Med Avail Ltd Abg12,851Open or private purchase$13.06$167,848.20
Myos Rens Technology
Myos Rens Technology logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.


MYOS RENS Technology, Inc. engages in the discovery, development, and commercialization of advanced nutrition products, functional foods, and other technologies. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk.


Ticker: MYOS
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1402479
Employees: 15
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
News